ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Adjuvant Chemotherapy with Gemcitabine Plus Cisplatin for Kidney Transplant Patients with Transitional Cell Carcinoma.

    Z. Wang, J. Lin, Y. Zhu, J. Zhang, J. Xiao, Y. Guo, Y. Tian.

    Urology, Beijing Friendship Hospital, Beijing, China

    Background: The purpose of this study was to evaluate the effects and safety of adjuvant chemotherapy with gemcitabine plus cisplatin in kidney transplant patients with…
  • 2017 American Transplant Congress

    Utility of a 10-Minute Functional Test as a Predictor of Kidney Transplant (KTP) Listing.

    M. Swee,1,2 J. Hornickel,2 R. Kalil.1,2

    1Transplant Nephrology, University of Iowa, Iowa City, IA; 2Transplant Nephrology, Iowa City Veterans Affairs Medical Center, Iowa City, IA

    Purpose: Frailty is a measure of physiologic reserve that has been associated with poor outcomes after kidney transplant, but its use as a predictor for…
  • 2017 American Transplant Congress

    The Treatment of the Graft and the Recipient with α-Lipoic Acid Improves the Delay Graft Function Severity in the Human Kidney Transplant.

    G. Weber,1 N. Ambrosi,2 F. Caro,2 S. Beltramino,1 A. Fernández,1 I. Cabrera,1 G. Hilchenbach,1 D. Fernandez,1 C. Incardona,3 E. Chuluyan,2 D. Casadei.1

    1Instituto de Nefrologia, Nephrology, Buenos Aires, Argentina; 2CEFYBO, Facultad de Medicina, UBA-CONICET, Buenos Aires, Argentina; 3Fundación GADOR, Buenos Aires, Argentina

    A previous pilot clinic trial had showed that treatment of the donor and recipient with a potent anti-oxidant such as α-lipoc acid (ALA) reduces the…
  • 2017 American Transplant Congress

    Development and Validation of an FLF-Transplant Score to Predict Mortality of Patients with Fulminant Liver Failure.

    Z. Guo, B. Chen, X. He, G. Chen.

    The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    BACKGROUND & AIMS: We aimed to develop a simple prognostic model in predicting fulminant liver failure (FLF) patient mortality within 14 days after being listed…
  • 2017 American Transplant Congress

    Exception Scores for Patients on the Liver Waiting List.

    T. Weaver,1 D. Schladt,1 M. Skeans,1 J. Pyke,1 J. Zeglin,1 S. Leppke,1 A. Israni,1,2 B. Kasiske,1,2 W. Kim,3 J. Lake.4

    1Scientific Registry of Transplant Recipients, Minneapolis, MN; 2Hennepin County Medical Center, Minneapolis, MN; 3Stanford University, Stanford, CA; 4University of Minnesota, Minneapolis, MN

    Liver waitlist candidates are prioritized for allocation using model for end-stage liver disease (MELD) scores, and some patients receive higher MELD scores through exception. The…
  • 2017 American Transplant Congress

    Impact of Intensive Dosing of Mycophenolate on Pancreas Allograft Survival.

    J. Fose,1 K. Rolling,1 N. Menninga,1 G. Leverson,2 M. Jorgenson,1 J. Odorico,2 R. Robert.2

    1Pharmacy, UW Health, Madison, WI; 2Transplant Surgery, UW Health, Madison, WI

    Purpose: The primary objective was to evaluate the effect of mycophenolate (MPA) dicharge (DC) dose on pancreas allograft (PTX) survival. Secondary endpoints included patient survival…
  • 2017 American Transplant Congress

    HLA Mismatching Does Not Have an Impact on Graft or Patient Survival in Simultaneous Kidney-Pancreas Transplantation. A Single Institution Experience.

    I. Moinuddin, M. Yaqub, T. Taber, D. Mishler, M. Mujtaba, J. Powelson, O. Adebiyi, J. Fridell, A. Sharfuddin.

    Indiana University Health, Indianapolis

    Purpose: There is conflicting data on whether the level and type of HLA mismatching (MM) has an impact on pancreas, kidney, or patient survival in…
  • 2017 American Transplant Congress

    Safety and Decreased Inflammation of Early Double Cytokine Blockade (IL-1β and TNF-α) Facilitates Engraftment in Islet Allotransplantation.

    N. Onaca,1 M. Takita,2 M. Levy,3 B. Naziruddin.1

    1Simmons Transplant Institute, Baylor University Medical Center, Dallas; 2Baylor Scott and White Research Institute, Dallas; 3Hume Lee Transplant Center, Virginia Commonwealth University, Richmond

    Enhanced early islet engraftment offers the potential for improved graft function after islet allotransplantation (IT). Nine patients underwent IT under a fully completed prospective research…
  • 2017 American Transplant Congress

    Long-Term Malignancy Risk in Kidney Transplant Recipients Treated with Cyclophosphamide Pre-Transplant for Native Glomerular Disease.

    J. Mills,1 M. Jorgenson,1 J. Fose,1 B. Astor,2 S. Panzer.2

    1Pharmacy, UW Health, Madison, WI; 2Nephrology, UW Health, Madison, WI

    Purpose: To evaluate the incidence of malignancy in kidney transplant recipients who previously received cyclophosphamide for treatment of native glomerular disease.Methods: Single center study of…
  • 2017 American Transplant Congress

    Induction of Durable Mixed Hematopoietic Chimerism and Immune Tolerance in Non-Human Primates.

    P. Alonso-Guallart,1 R. Duran-Struuck,1 J. Stern,1 S. Kofman,1 M. Danton,1 J. Zitsman,1 Y. Kato,1 E. Berglund,1 H. Sondermeijer,1 A. McMurchy,2 M. Levings,2 M. Sykes,1 A. Griesemer.1

    1Columbia Center for Translational Immunology, Columbia University, New York, NY; 2University of British Columbia, Vancouver, Canada

    Mixed hematopoietic chimerism is a promising approach to achieving transplantation tolerance. Transient mixed chimerism leads to renal allograft tolerance in about 70% of cynomolgus macaques…
  • « Previous Page
  • 1
  • …
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences